Eli Lilly Software Development Engineer (SDE) System Design Interview Guide 2026
TL;DR
Eli Lilly’s SDE system design interviews test scalability, data modeling, and pharmacy domain awareness—not just generic tech patterns.
Candidates fail by treating them like FAANG interviews; success requires aligning technical tradeoffs with healthcare compliance and real-world drug lifecycle systems.
The process spans 3–5 weeks, includes 2–3 technical rounds, and hinges on demonstrating judgment under regulatory constraints.
Who This Is For
This guide targets mid-level to senior software engineers with 3–8 years of experience applying for SDE roles at Eli Lilly, particularly those transitioning from consumer tech to regulated enterprise environments.
It’s for engineers who’ve cleared phone screens but stall in system design due to misaligned expectations—especially those who assume cloud-scale patterns trump domain-specific constraints.
If your background is in fintech, e-commerce, or SaaS and you lack exposure to HIPAA, GxP, or batch processing in pharma manufacturing, this is your calibration.
What does Eli Lilly’s SDE system design interview actually test?
Eli Lilly doesn’t assess raw throughput or microservice dogma; they test whether you can build systems that survive audit trails, versioned data, and decade-long data retention.
In a Q3 2025 hiring committee meeting, two candidates proposed Kafka for event streaming in a clinical trial data ingestion pipeline—one passed, one failed. The difference wasn’t architecture quality.
The failing candidate optimized for latency and partitioning; the passing candidate justified Kafka only after ruling out auditable file staging and outlining how message schemas would be version-controlled under FDA 21 CFR Part 11.
Not scalability, but data lineage.
Not uptime, but reproducibility.
Not elegance, but traceability.
Eli Lilly runs systems where a single data point error can invalidate years of clinical research.
Their engineers must design for retrospective analysis, not just forward performance.
This means you’ll be evaluated on how you handle data immutability, audit logging, role-based access with justification trails, and schema evolution in regulated contexts.
A 2024 debrief revealed a senior candidate from Amazon was rejected despite a flawless distributed cache design because they dismissed “manual reconciliation steps” as legacy—missing that those steps were FDA-mandated checkpoints.
The hiring manager said: “We don’t eliminate process; we automate it without breaking chain of custody.”
Judgment signal: When discussing tradeoffs, explicitly name the compliance or operational risk you’re mitigating.
For example: “I’m choosing append-only tables not for durability, but to preserve audit history required under GCP guidelines for trial data.”
How is Eli Lilly’s system design round different from FAANG?
The core difference isn’t tools or scale—it’s that Eli Lilly prioritizes consistency over availability in nearly all cases, violating the typical FAANG bias toward eventual consistency.
In healthcare systems handling patient dosing records or compound formulations, divergent states aren’t bugs—they’re liabilities.
In a 2025 interview simulation, a candidate proposed eventual consistency between inventory and dispensing systems using background reconciliation.
The interviewer stopped them at 12 minutes: “If a nurse pulls a vial based on stale inventory, and the system later reconciles to ‘out of stock,’ who bears responsibility? The nurse? The system? We can’t have that ambiguity.”
The expected design enforced synchronous validation with circuit-breaking fallbacks—not CRDTs or conflict resolution.
Not fault tolerance, but accountability.
Not developer velocity, but change control.
Not innovation, but validation.
Eli Lilly’s systems operate under validation protocols where every component must be tested, documented, and approved before deployment.
This means your design must include versioning strategies for APIs, data models, and business rules—not as an afterthought, but as a primary constraint.
A real 2024 prompt asked candidates to design a system for managing temperature logs from drug storage units.
Top performers didn’t jump to IoT ingestion pipelines. They first defined data ownership (site vs. cloud), retention policies (7+ years for audit), and how recalibration events would be logged as immutable records.
One candidate scored exceptionally by proposing digital signatures on log batches to prevent tampering—directly addressing 21 CFR Part 11 electronic record requirements.
FAANG interviews reward speed and pattern application.
Eli Lilly rewards caution and traceability.
If your design doesn’t include how changes are approved, logged, and rolled back under audit, you’re designing for the wrong threat model.
What’s the typical system design interview structure and timeline?
You get one 60-minute system design interview, usually in the final onsite round, following a coding screen and behavioral round.
The timeline from resume submission to offer averages 22 days—faster than FAANG but slower than startups—with 80% of candidates failing at the onsite stage.
The session starts with a 5-minute setup where the interviewer describes the domain context: e.g., “Design a system for tracking adverse event reports from clinics.”
You then have 50 minutes to lead the discussion. Interviewers expect you to ask clarifying questions about data sensitivity, reporting deadlines, and integration points—missing these costs more than technical gaps.
In a HC review last year, a candidate was dinged for not asking whether the adverse event data would feed into EudraVigilance (the EU pharmacovigilance database).
The hiring manager stated: “They treated it as a generic form submission system. But if you don’t know it must meet ICH E2B standards, you can’t design the schema correctly.”
Expect minimal emphasis on load numbers.
You won’t be asked to calculate QPS or shard counts.
Instead, you’ll be pushed on how data flows through review workflows, how duplicates are detected across sources, and how corrections are handled without erasing history.
Interviewers are often domain engineers—people who built the actual adverse event systems—not generalist L5s.
They listen for awareness of business processes: for example, that a single adverse event might trigger follow-up queries, require medical review, and generate time-bound regulatory submissions.
Your success metric isn’t whether the system scales to 10M users.
It’s whether a compliance officer could reconstruct every decision path six years later.
How should I structure my answer in the interview?
Start with scope and compliance, not components or APIs.
The first three minutes should define: data classification (PHI? proprietary?), regulatory frameworks (HIPAA, 21 CFR Part 11), and key workflows (submission, review, reporting).
Fail to do this, and everything you build will feel misaligned—even if technically sound.
In a debrief, a candidate built a clean event-driven architecture using AWS services but lost points because they didn’t identify that adverse event data qualifies as Protected Health Information (PHI) under HIPAA.
The interviewer noted: “They designed for scale, but not for de-identification requirements during analytics processing.”
Use this framing:
- Bound the problem (Who inputs? Who consumes? What are the deadlines?)
- Identify constraints (Retention: 25 years for some trials. Access: only pharmacovigilance staff with dual approval.)
- Sketch core data model (Focus on audit fields: createdby, reviewedat, version_chain.)
- Map workflow states (e.g., “Reported” → “Triage” → “Medically Reviewed” → “Regulatory Submitted”)
- Add infrastructure second (Now pick storage, messaging, auth—justified by prior constraints.)
Not components, but custody.
Not performance, but provenance.
Not elegance, but explainability.
A top-scoring candidate in 2024 designed an adverse event system by first listing the ICH E2B fields, then defining lifecycle states, then choosing PostgreSQL with row-level security and a changelog trigger—because they needed transactional integrity across status updates and audit trails.
They rejected Kafka despite high volume because batch validation was required before any event entered the workflow.
Your diagrams matter less than your narrative.
Interviewers don’t expect UML.
They expect you to speak in terms of data lifecycles, not service boundaries.
One candidate drew a single box labeled “Adverse Event Store” with six attributes and still passed—because they spent 20 minutes explaining how each field would be verified, who could change it, and how corrections would be appended rather than overwritten.
What are common system design topics at Eli Lilly?
Expect prompts in pharmacovigilance, clinical trial data management, supply chain traceability, and lab instrument integration—not social feeds or ride-sharing.
You’re more likely to design a system for tracking drug batch recalls than a recommendation engine.
Recent prompts include:
- “Design a system to collect and validate temperature data from refrigerated trucks”
- “Build a workflow for reviewing and escalating patient adverse event reports”
- “Create a data pipeline for aggregating lab results from contract research organizations (CROs)”
These are not hypothetical.
They mirror real systems used in Eli Lilly’s global operations.
Interviewers pull from active projects or recent outages.
For the temperature monitoring prompt, strong candidates immediately asked:
- What’s the sampling frequency? (Answer: every 5 minutes)
- Who owns calibration? (Answer: third-party logistics, so data must include device ID and last calibration date)
- Is real-time alerting required? (Answer: yes, for >2°C deviation for >15 minutes)
They then designed with immutable time-series tables, digital signatures on data batches, and fallback manual entry modes—knowing that paper logs are still used in some regions and must be reconciled.
One candidate failed by proposing MQTT for real-time telemetry but didn’t address how disconnected trucks would backfill data.
The system requires guaranteed delivery with deduplication—something MQTT alone doesn’t solve without additional idempotency layers.
Another candidate succeeded by proposing a hybrid: edge devices buffer locally, then upload via HTTPS with checksums and timestamps, with a reconciliation service to merge and flag gaps.
They justified PostgreSQL TimescaleDB over InfluxDB because it supports row-level security and easier audit joins with user tables.
Domain knowledge gaps are disqualifying.
If you don’t know that a drug batch has a unique serial, lot number, and expiration—and that recalls must propagate across countries within 4 hours—you’ll design the wrong indexing strategy.
Work through a structured preparation system (the PM Interview Playbook covers healthcare system design with real debrief examples from pharma and medtech firms, including FDA compliance patterns and audit-safe data modeling).
Preparation Checklist
- Study ICH E2B, 21 CFR Part 11, and HIPAA minimum necessary standards—focus on how they impact data design
- Practice designing workflows with state transitions and approval chains, not just CRUD APIs
- Memorize key pharma data entities: patient, trial site, adverse event, drug batch, dispensing record
- Build fluency in immutable logging, changelog patterns, and digital signature validation
- Work through a structured preparation system (the PM Interview Playbook covers healthcare system design with real debrief examples from pharma and medtech firms, including FDA compliance patterns and audit-safe data modeling)
- Do mock interviews with engineers who’ve worked in regulated environments—FAANG mocks won’t transfer
- Prepare 2–3 examples from your past where you designed for audit, compliance, or long-term data integrity
Mistakes to Avoid
- BAD: Starting with scalability assumptions.
A candidate began a supply chain design with “Assume 10M requests per second” and was immediately redirected: “We have hundreds of depots, not millions of users. Focus on data accuracy across handoffs.”
Guessing scale shows you’re applying a template, not thinking.
- GOOD: Starting with data ownership and regulatory scope.
Another candidate opened with: “First, I need to know if this data will be subject to FDA inspection, and whether we’re tracking chain of custody for controlled substances.”
That question alone elevated their score—it showed they design with liability in mind.
- BAD: Proposing eventual consistency for inventory systems.
One engineer suggested async updates between warehouse and dispensing systems.
The interviewer responded: “If two sites dispense the last two vials of a drug based on stale data, that’s a patient risk. We need synchronous checks with fallback to manual verification.”
- GOOD: Designing for reconciliation, not just real-time sync.
A top performer proposed a hybrid model: real-time checks when possible, but with hourly batch audits and exception reports for discrepancies.
They explained: “In pharma, we don’t trust real-time alone. We need paper-and-digital alignment.”
- BAD: Ignoring manual processes.
Candidates often dismiss paper forms or offline entry as “legacy.”
But in clinical trials, source data often starts on paper.
A design that doesn’t account for scanning, verification, and reconciliation will fail.
- GOOD: Explicitly planning for hybrid data entry.
One candidate drew a “manual entry station” box with double-data-entry validation and audit trails.
The interviewer nodded: “That’s how we actually do it in Phase I trials. You’re thinking about operations, not just code.”
FAQ
Do I need to know pharmacology to pass the system design interview?
No, but you must understand data governance in regulated contexts. Interviewers don’t expect drug mechanism expertise, but they do expect awareness of how data is used in safety reporting, audits, and regulatory submissions. Not biochemistry, but compliance workflows.
Is distributed systems knowledge still important?
Yes, but applied differently. You’ll need to know consistency models, fault tolerance, and data replication—but the evaluation focuses on how these choices affect auditability and reproducibility, not just uptime or speed. Not availability, but verifiability.
What if I have no healthcare experience?
Focus on transferable constraints: financial auditing, legal holds, or safety-critical systems. Frame past projects around data integrity, change control, and compliance. Interviewers value structured thinking over domain familiarity—if you ask the right scoping questions. Not experience, but judgment.
Ready to build a real interview prep system?
Get the full PM Interview Prep System →
The book is also available on Amazon Kindle.